Cogmotiv FlexCo is a neuroscience-focused biotech company developing the first disease-modifying treatment for apathy in dementia. We target this critical unmet need with a novel small-molecule approach grounded in cutting-edge neuroscience. Our lead program is advancing through preclinical development toward regulatory approval and commercialisation.